Investment
Features
FeesSafety
Academy
More
Pluang+

Dynagas LNG Partners LP undervalued at 0.28x book value with 6.1% yield and growth potential to 2029

Market News
20 Oct 2026
Seeking Alpha
View Source
Bullish
Dynagas LNG Partners LP undervalued at 0.28x book value with 6.1% yield and growth potential to 2029

Dynagas LNG Partners LP is trading at a deep discount of 0.28 times its book value, offering a 6.1% yield and significant upside potential. The company’s redemption of two million Series A preferred units will cut annual distribution costs by $4.5 million, boosting profitability and capital efficiency for common equity holders. A financial model projects the book value per common unit to rise from $11.71 to $15.50 by 2029, assuming stable earnings and disciplined debt repayment. Despite risks like sanctions and charter coverage, the current discount and improved cash flow support a Buy rating with a $6 valuation target.

Dynagas LNG Partners offers context for energy sector investors. For readers following energy stocks, here is Pluang's market snapshot as of Oct 21, 2026 03:42 WIB: 44 of 79 priced US energy stocks rose, 33 fell. Notable movers include PTEN at USD 11.66 with 0% sell and 100% buy activity, TTE at USD 91.28 with 100% sell activity, and LBRT at USD 16.59 with a 1-day change of -2.93%.

More News

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...

Company Fundamentals
Neutral
18 minutes ago
Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...

Company Fundamentals
Bullish
20 minutes ago
Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
1 hour ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
2 hours ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App